Molecular Targets and Strategies in Cancer Prevention

Strategies to Target Pancreatic Cancer.- MICROBIOTA AND CHRONIC INFLAMMATION AS TARGETS FOR COLORECTAL CANCER PREVENTION.- Challenges in multiple myeloma chemoprevention: potential role of natural, synthetic and endogenous molecules.- Targeting MicroRNAs: Molecular basis of cancer prevention.- A new level of complexity in cancer regulation and a promising source of biomarkers: The liquid biopsies.- Targeting Tumor Angiogenesis for Cancer Prevention.- Molecular Targets and Strategies in Cancer Prevention

Dr. Malay Chatterjee, PhD, DSc, FAScT, is Emeritus Professor from the Department of Pharmaceutical Technology at Jadavpur University (India). He is also a Member of Pharmaceutical Education Board for the Government of India. Dr. Chatterjee has published over 165 scientific papers, 8 book chapters, and he has edited two contributed volumes--one is entitled Cell Signaling & Molecular Targets in Cancer, which was published by Springer in 2012. He is an Editorial Board member of several journals including, Research Journal of Medical Science, European Journal of General Medicine, and International Journal of Pharmacology, to name a few. He has received over 2122 citations.
Dr. Pierfrancesco Tassone is currently a Professor of Medical Oncology at the University "Magna Graecia" of Catanzaro. Dr. Tassone's research has taken him from the New York Medical College in Valhalla, NY to the Comprehensive Cancer Center, University of California San Diego, and later to the Dana Farber Cancer Institute and Harvard Medical School in Boston, Massachusetts. His research focuses on an approach of translational research integrating modern molecular acquisitions and new technologies to the methodological criteria of evidence-based medicine. In particular, Dr. Tassone generated monoclonal antibodies, identifying new tumor-associated antigens, and in recent years has studied the targeting of the tumor microenvironment for the development of new therapeutic strategies especially directed to multiple myeloma and methods of individualization of treatments cancer based on the genetic context and frameworks of hereditary-familial predisposition of breast cancer. He is author of over one hundred publications in prestigious international journals and has presented at conferences worldwide.